New IHE publication on a conceptual modelling framework to assess the cost-effectiveness of molecularly targeted therapies in oncology
By annette
As part of our work in PRIMEROSE WP5, IHE has contributed to a publication that highlights challenges and possible solutions for how molecularly targeted therapies can be evaluated from a health economic perspective.